Table 1. Cohort demographic and clinical characteristics.
No (%) of subjects | ||
Sex | ||
Male | 82 (49.6%) | |
Female | 83 (50.4%) | |
| ||
Age | ||
Median | ||
Male: | 30.5 yrs. (16 – 57) | |
Female: | 31.7 yrs. (18 – 61) | |
| ||
Ethnic origin | ||
African-American | 165 (100%) | |
SCD genotype | ||
SS | 161 (97.5%) | |
SB Thal° | 3 (1.8%) | |
S-Los Angeles | 1 (0.6%) | |
| ||
BMI | ||
Median | ||
Male: | 23.1 (15.3 – 35.2) | |
Female: | 23.7 (16.5 – 38.4) | |
| ||
NSAIDs | Ibuprofen (Motrin, Advil) | 50 (30.3%) |
Naproxen (Aleve) | 10 (6.1%) | |
Aspirin | 5 (3%) | |
Acetaminophen (Tylenol) | 20 (12.1%) | |
| ||
Hydroxyurea therapy | Yes | 110 (67%) |